SBIR-STTR Award

Identifying compounds that increase mitochondrial performance
Award last edited on: 10/26/2012

Sponsored Program
STTR
Awarding Agency
DOD : Army
Total Award Amount
$849,986
Award Phase
2
Solicitation Topic Code
A08-T006
Principal Investigator
Gino Cortopassi

Company Information

Eon Research Corporation (AKA: Gerontech~Mitodyne Inc~Eon Corporation)

707 4th Street Suite 305
Davis, CA 95616
   (530) 756-6903
   info@eonresearch.com
   www.eonresearch.com

Research Institution

----------

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2008
Phase I Amount
$100,000
The objective of this proposal is to isolate drugs that will enhance human physical and cognitive performance and resilience to trauma through enhancement of mitochondrial function. The significance of this opportunity is to reduce biological constraints on the modern army. Smaller, faster-moving fighting forces are constrained by physical endurance, which in turn is directly related to number and efficiency of muscle mitochondria. Additionally, mitochondrial function declines with age, contributing to the age-related loss of physical and cognitive performance. Experienced soldiers are forced to retire because of these losses of performance. Finally, field trauma leads to tissue death when metabolic reserves are insufficient. We have modified a high-throughput cell-based assay to sensitively monitor mitochondrial function, and will use this assay to screen for compounds increasing mitochondrial performance, through increased proliferation or increased electron transfer. We demonstrate that the assay detects a known mitoproliferation drug, and will optimize the assay for screening in 96 and 384-well plates in Phase I. In Phase II multiple drug and natural compound libraries will be screened, and mito-active drugs identified. The discovery of mitochondrial enhancers would represent an important step toward improving human performance and trauma resistance through augmentation of mitochondrial function througout aging.

Keywords:
Mitochondria, Performance, Aging, Oxygen, Endurance, Trauma, Resistance,

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2010
Phase II Amount
$749,986
Defects of mitochondrial performance limit physical and cognitive endurance, and resistance to age-related deterioration and trauma. However large scale screens to identify drug-like compounds that improve mitochondrial function have not taken place, bec

Keywords:
Mitochondria, Human Performance, Trauma Resistance, Aging